Projected health and economic effects of nonavalent versus bivalent human papillomavirus vaccination in preadolescence in the Netherlands
Sex-neutral vaccination with the nonavalent vaccine is likely to be cost-effective. Long-term monitoring of type-specific vaccine effectiveness is essential because of the impact of cross-protection and waning efficacy on cost-effectiveness.
Authors
- Birgit Sollie (ORCID: https://orcid.org/0000-0002-6269-0575)
- Johannes Berkhof (ORCID: https://orcid.org/0000-0003-2094-2380)
- Johannes A. Bogaards (ORCID: https://orcid.org/0000-0002-3389-5141)
Institutions
- GGD Amsterdam (NL)
- Cancer Center Amsterdam (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- BMC Medicine
- Published
- 2025-06-08
- DOI
- https://doi.org/10.1186/s12916-025-04170-3
- Citations
- 1
- Primary Topic
- Cervical Cancer and HPV Research
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- ZonMw